The Houston Methodist Blanton Eye Institute is looking ahead to the future, investing time and resources in both research and technology. We are innovating in clinical care for the following important eye diseases and procedures
- Ocular oncology
- Diabetic retinopathy
- Thyroid ophthalmopathy
- Ocular infectious
- Ocular inflammatory diseases
- Ocular stem cell and gene therapies
- Neuroprotection in neuroophthalmology and glaucoma
At Houston Methodist, we invest in bringing new technology to our patients. By providing the best, most up-to-date equipment and services, we are better able to help the patients who seek treatment for some of the most challenging and complex cases. This is why Houston Methodist offers state-of-the-art neuroimaging technology in the form of a 3 Tesla (3T) magnetic resonance image (MRI) magnet and 64-slice computed tomography (CT) scanner, as well as treatment options, such as stereotactic conformal radiotherapy, image-guided therapies, TomoTherapy® and linear accelerator technology.
By stewarding technological breakthroughs and using the technology we already have at hand to the best advantage, we are confident that we can realize our goal: taking care of the eyes of tomorrow through our hard work today. Join our team as a colleague or a collaborator and become a part of the next generation of innovators in ophthalmology.